Skip to the page content
Passes our checks

Answer2cancer

EIN 81-4885713 · Beaverton, OR

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthNot ratedToo small or too little detailGovernanceNot ratedThe short tax form does not cover thisImpact evidenceDescribes programsHow well its results are evidenced

What it says it does

Answer2Cancer, Inc. is by and for patients who, while going through cancer treatments, realized they didn't know what they didn't know. Those undergoing treatment (and their caregivers) know there is so much to know. Answer2Cancer, Inc. has been created to help patients and their caregivers/helpers overcome the challenges of treatments and learn helpful, healthful survivor strategies.

Income
$1
Spending
$10,388
Reserves
18.5 months of spending
Largest source of income
investment income, 100%

Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

We do not score finances when yearly spending is very small or the return has too little detail. The ratios stop meaning much at that size.

Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

This organization files the short tax form, which does not ask about boards, policies or audits. That is normal for a small charity and is not a mark against it.

Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (5)
  1. In 2018, we held Answer2Cancer, Inc. full day event to bring resources, support and education at no charge to Portland, Oregon area cancer patients, their families and caregivers. Nearly 300 people attended the April 7, 2018 event. We also made presentations to community and health groups including Portland Oncology Pharmeceutical Society's leadership team. Additionally, we traveled to and began planning for 2019 and 2020 events in Bellingham, Spokane and the Tri-Cities, Washington. The 2020 event due to COVID-19, was held through an on-line format to reach those who were at higher risk due to suppressed immune systems. The event was held on October 3, 2020 and was title "Answer2Cancer Digital 2020" The event was attended by approximately 275 on-line attendees. In 2021, the focus of the year was education and outreach planning for events in 2022 and 2023.
  2. Activities and planning 2022-responded and wrote two small Advocacy grants to Pfizer and also applied for Advocate grant from PhRMA. In, October of 2022 traveled to Missoula and Billings Montana regarding the possibility of bringing the A2C program to MT in 2023. Received a favorable reception at both locations from representatives of Johnson & Johnson and the American Cancer Society's Cancer Action Network local director. Following up with Community Cancer Centers In MT and other organizations to begin the process for a summer 2023 event. In October of 2022, also traveled to Boise, ID meeting with a clinical trial specialist who is affiliated with a large health care system there at St. Luke's.
  3. In 2023, we continued planning for 2024 patient education and support events in Eugene, Billings Montana and Boise Idaho. We worked closely with therapeutical companies to engage in patient education efforts with local health providers, policymakers and patient advocate organizations, to improve access to medicines for the underserved.
  4. A2C was invited to submit an Advocacy grant to Pfizer, which was funded at $10,000. Funds are being used on a digital media to support/increase awareness of a national patient survey to determine drug cost variables for patients and families. For 2025, working on a pitch for an A2C event in Eugene, in cooperation with the Willamette Valley Cancer institute in Eugene and throughout Lane County
  5. 2025-Challenging year of reaching out to make deeper partnerships, attended Advocacy Day in Salem. Seeking viable sponsors for 2026 events. Pharmaceutical companies are changing their models and it is more difficult to obtain partnerships for events and programs. Cuts to Federal funding and stronger competition for dollars is creating a challenging environment. The Focus for this year was to develop relationships with partners for smaller events with smaller costs and larger impact. These take time to develop and move through the process. In 2025 A2C was invited to participate in the Advocacy activities with Vertex at the Oregon Capitol in March of 2025. Goal for 2026 is focused on a potential partnership and A2C event in Eugene, in cooperation with the Salem Cancer Community, Oregon Oncology Specialists and Willamette Valley Cancer Institute in Eugene/Lane County.

Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2025.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since April 2017.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.